After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
Crucial life-saving initiative led by Dr. Steven Quay for clinical trials on the safety and efficacy of a combination of FDA-approved drugs (nebulized Heparin-N-acetylcysteine in COVID-19 Patients by ...
A physician says a combination of drugs could prevent coronavirus patients from needing ventilators. Dr Steven Quay is hoping to get a clinical trial started to see the effect of two medications, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback